These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 34871474)

  • 1. Commentary on the harm reduction reference group of justice health and forensic mental health network and corrective services NSW, Australia.
    Silano JA; Treloar C; Wright T; Brown T; McGrath C; Snoyman P
    Int J Prison Health; 2022 Nov; 18(4):394-406. PubMed ID: 34871474
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lessons learned from keeping NSW's prisons COVID-free.
    Blogg J; McGrath C; Galouzis J; Grant L; Hoey W
    Int J Prison Health; 2021 Oct; 17(3):398-405. PubMed ID: 33709638
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The furthest left behind: the urgent need to scale up harm reduction in prisons.
    Sander G; Murphy F
    Int J Prison Health; 2017 Sep; 13(3-4):185-191. PubMed ID: 28914120
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Priorities and recommended actions for how researchers, practitioners, policy makers, and the affected community can work together to improve access to hepatitis C care for people who use drugs.
    Day E; Broder T; Bruneau J; Cruse S; Dickie M; Fish S; Grillon C; Luhmann N; Mason K; McLean E; Trooskin S; Treloar C; Grebely J
    Int J Drug Policy; 2019 Apr; 66():87-93. PubMed ID: 30743093
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of an evidence-based hepatitis C education program to enhance public health literacy in the Australian prison sector: The Hepatitis in Prisons Education program (HepPEd).
    Sheehan Y; Lafferty L; Tedla N; Byrne M; Dawson O; Stewart S; Leber B; Habraken N; Lloyd AR
    Int J Drug Policy; 2024 Jul; 129():104461. PubMed ID: 38971019
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Barriers and advocacy needs for hepatitis C services in prisons: Informing the prisons hepatitis C advocacy toolkit.
    Walker SJ; Shrestha LB; Lloyd AR; Dawson O; Sheehan Y; Sheehan J; Maduka NBC; Cabezas J; Akiyama MJ; Kronfli N;
    Int J Drug Policy; 2024 Apr; 126():104386. PubMed ID: 38492433
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Experience and Effectiveness of Nurse Practitioners in Orthopaedic Settings: A Comprehensive Systematic Review.
    Taylor A; Staruchowicz L
    JBI Libr Syst Rev; 2012; 10(42 Suppl):1-22. PubMed ID: 27820153
    [TBL] [Abstract][Full Text] [Related]  

  • 8. "You need a designated officer" - Recommendations from correctional and justice health personnel for scaling up hepatitis C treatment-as-prevention in the prison setting.
    Lafferty L; Rance J; Byrne M; Milat A; Dore GJ; Grebely J; Lloyd AR; Treloar C;
    Int J Drug Policy; 2022 Aug; 106():103746. PubMed ID: 35636069
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integrating multiple programme and policy approaches to hepatitis C prevention and care for injection drug users: a comprehensive approach.
    Birkhead GS; Klein SJ; Candelas AR; O'Connell DA; Rothman JR; Feldman IS; Tsui DS; Cotroneo RA; Flanigan CA
    Int J Drug Policy; 2007 Oct; 18(5):417-25. PubMed ID: 17854731
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatitis C in Australian prisons: a national needs assessment.
    Mina MM; Herawati L; Butler T; Lloyd A
    Int J Prison Health; 2016; 12(1):3-16. PubMed ID: 26933988
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined treatment and prevention strategies for hepatitis C virus elimination in the prisons in New South Wales: a modelling study.
    Bretaña NA; Gray RR; Cunningham EB; Betz-Stablein B; Ribeiro R; Graw F; Luciani F; Lloyd AR
    Addiction; 2020 May; 115(5):901-913. PubMed ID: 31633853
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and evaluation of a de-escalation training intervention in adult acute and forensic units: the EDITION systematic review and feasibility trial.
    Price O; Papastavrou Brooks C; Johnston I; McPherson P; Goodman H; Grundy A; Cree L; Motala Z; Robinson J; Doyle M; Stokes N; Armitage CJ; Barley E; Brooks H; Callaghan P; Carter LA; Davies LM; Drake RJ; Lovell K; Bee P
    Health Technol Assess; 2024 Jan; 28(3):1-120. PubMed ID: 38343036
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatitis C elimination among people incarcerated in prisons: challenges and recommendations for action within a health systems framework.
    Akiyama MJ; Kronfli N; Cabezas J; Sheehan Y; Thurairajah PH; Lines R; Lloyd AR;
    Lancet Gastroenterol Hepatol; 2021 May; 6(5):391-400. PubMed ID: 33857445
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beyond the black stump: rapid reviews of health research issues affecting regional, rural and remote Australia.
    Osborne SR; Alston LV; Bolton KA; Whelan J; Reeve E; Wong Shee A; Browne J; Walker T; Versace VL; Allender S; Nichols M; Backholer K; Goodwin N; Lewis S; Dalton H; Prael G; Curtin M; Brooks R; Verdon S; Crockett J; Hodgins G; Walsh S; Lyle DM; Thompson SC; Browne LJ; Knight S; Pit SW; Jones M; Gillam MH; Leach MJ; Gonzalez-Chica DA; Muyambi K; Eshetie T; Tran K; May E; Lieschke G; Parker V; Smith A; Hayes C; Dunlop AJ; Rajappa H; White R; Oakley P; Holliday S
    Med J Aust; 2020 Dec; 213 Suppl 11():S3-S32.e1. PubMed ID: 33314144
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Legal prison tattooing centers: viable health policy initiative?
    Awofeso N
    J Public Health Manag Pract; 2010; 16(3):240-4. PubMed ID: 20357610
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Considering treatment-as-prevention scale-up for Australian prisons: a qualitative sub-study of expert stakeholders from the Australian 'surveillance and treatment of prisoners with hepatitis C' project (SToP-C).
    Rance J; Lafferty L; Treloar C;
    Harm Reduct J; 2021 Apr; 18(1):46. PubMed ID: 33902595
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incarcerated aboriginal women's experiences of accessing healthcare and the limitations of the 'equal treatment' principle.
    Kendall S; Lighton S; Sherwood J; Baldry E; Sullivan EA
    Int J Equity Health; 2020 Apr; 19(1):48. PubMed ID: 32245479
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prison-based interventions are key to achieving HCV elimination among people who inject drugs in New South Wales, Australia: A modelling study.
    Stone J; Lim AG; Dore GJ; Borquez A; Geddes L; Gray R; Grebely J; Hajarizadeh B; Iversen J; Maher L; Valerio H; Martin NK; Hickman M; Lloyd AR; Vickerman P
    Liver Int; 2023 Mar; 43(3):569-579. PubMed ID: 36305315
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Palliative and end-of-life care in prisons: a content analysis of the literature.
    Maschi T; Marmo S; Han J
    Int J Prison Health; 2014; 10(3):172-97. PubMed ID: 25764177
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Testing, diagnosis, and treatment following the implementation of a program to provide dried blood spot testing for HIV and hepatitis C infections: the NSW DBS Pilot.
    Carrington N; Conway A; Grebely J; Starr M; Catlett B; Stevens A; Prain B; McGrath C; Causer L; Guy R; Holden J; Keen P; Kingsland M; Lu H; Power C; Read P; Murray C; McNulty A; Cunningham P;
    BMC Infect Dis; 2024 Jan; 24(1):137. PubMed ID: 38287234
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.